Andrew Cheng

President & Chief Executive Officer at Akero Therapeutics, Inc.

Andrew Cheng

Andrew Cheng

President & Chief Executive Officer at Akero Therapeutics, Inc.

Biography

Andrew Cheng holds the position of President, Chief Executive Officer & Director at Akero Therapeutics, Inc. Dr. Cheng is also on the board of Arbutus Biopharma Corp. and Syntimmune, Inc. In his past career he was Executive VP-HIV Therapeutics Operations at Gilead Sciences, Inc. Dr. Cheng received an undergraduate degree from The Johns Hopkins University and a doctorate from Columbia University College of Physicians & Surgeons.

Overview
Career Highlights

Akero Therapeutics, Inc.

RelSci Relationships

535

Number of Boards

6

Birthday

1967

Age

52

Relationships
RelSci Relationships are individuals Andrew Cheng likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Executive Vice President, Worldwide Commercial Operations at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former Chief Patient Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former Chief Operating Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Former Head-Media Relations at Gilead Sciences, Inc.

Relationship likelihood: Strong

Founder at Apple Tree Partners

Relationship likelihood: Strong

Chief Operating Officer & Co-Founder at Akero Therapeutics, Inc.

Relationship likelihood: Strong

Managing Director & Head of US Life Sciences at Deutsche Bank AG

Relationship likelihood: Strong

Partner at Apple Tree Partners

Relationship likelihood: Strong

Partner at Atlas Venture, Inc.

Relationship likelihood: Strong

Co-Founder at Arbutus Biopharma Corp.

Relationship likelihood: Strong

Paths to Andrew Cheng
Potential Connections via
Relationship Science
You
Andrew Cheng
President & Chief Executive Officer at Akero Therapeutics, Inc.
Education
Undergraduate Degree

The Johns Hopkins University opened in 1876, with the inauguration of its first president, Daniel Coit Gilman. "What are we aiming at?" Gilman asked in his installation address. "The encouragement of research ... and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell." The mission laid out by Gilman remains the university's mission today, summed up in a simple but powerful restatement of Gilman's own words: "Knowledge for the world." What Gilman created was a research university, dedicated to advancing both students' knowledge and the state of human knowledge through research and scholarship. Gilman believed that teaching and research are interdependent, that success in one depends on success in the other. A modern university, he believed, must do both well. The realization of Gilman's philosophy at Johns Hopkins, and at other institutions that later attracted Johns Hopkins-trained scholars, revolutionized higher education in America, leading to the research university system as it exists today. After more than 130 years, Johns Hopkins remains a world leader in both teaching and research. Eminent professors mentor top students in the arts and music, the humanities, the social and natural sciences, engineering, international studies, education, business and the health professions. Those same faculty members, and their research colleagues at the university's Applied Physics Laboratory, have each year since 1979 won Johns Hopkins more federal research and development funding than any other university. The university has nine academic divisions and campuses throughout the Baltimore-Washington area. The Krieger School of Arts and Sciences, the Whiting School of Engineering, the School of Education and the Carey Business School are based at the Homewood campus in northern Baltimore. The schools of Medicine, Public Health, and Nursing share a campus in east Baltimore with The Johns Hopkins Hospital. The Peabody Institute, a leading professional school of music, is located on Mount Vernon Place in downtown Baltimore. The Paul H. Nitze School of Advanced International Studies is located in Washington's Dupont Circle area. The Applied Physics Laboratory is a division of the university co-equal to the nine schools, but with a non-academic, research-based mission. APL, located between Baltimore and Washington, supports national security and also pursues space science, exploration of the Solar System and other civilian research and development. Johns Hopkins also has a campus near Rockville in Montgomery County, Md., and has academic facilities in Nanjing, China, and in Bologna, Italy. It maintains a network of continuing education facilities throughout the Baltimore-Washington region, including centers in downtown Baltimore, in downtown Washington and in Columbia. When considered in partnership with its sister institution, the Johns Hopkins Hospital and Health System, the university is Maryland's largest employer and contributes more than $10 billion a year to the state's economy

Columbia University College of Physicians and Surgeons, often known as P&S, is a graduate school of Columbia University that is located in the Columbia University Medical Center in the Washington Heights neighborhood of Manhattan. Founded in 1767 by Samuel Bard as the medical department of King's College (now Columbia University), the College of Physicians and Surgeons was the first medical school in the thirteen colonies and hence, the United States, to award the Doctor of Medicine (M.D.) degree. Beginning in 1993, P&S also was the first U.S. medical school to hold a White Coat Ceremony.

Doctorate Degree

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Career History
President & Chief Executive Officer
2018 - Current

Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.

Chief Medical Officer & Executive Vice President
1999 - 2018

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Boards & Committees
Director
Tenure Unconfirmed
Transactions
Details Hidden

Akero Therapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Andrew Cheng. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Andrew Cheng's profile does not indicate a business or promotional relationship of any kind between RelSci and Andrew Cheng.